Results 211 to 220 of about 26,736 (234)

Tumor board presentation of a woman with metastatic, hormone receptor‐positive, mismatch repair‐deficient endometrial cancer

Ca-A Cancer Journal for Clinicians, 2022
Jennifer A Bennett, Gini F Fleming
exaly  

Plant hormone regulation of abiotic stress responses

Nature Reviews Molecular Cell Biology, 2022
Rainer Waadt, Po-Kai Hsu, Yohei Takahashi   +2 more
exaly  

Breast cancer statistics, 2019

Ca-A Cancer Journal for Clinicians, 2019
Carol E Desantis, Jiemin, Mia M Gaudet
exaly  

Breast cancer statistics, 2017, racial disparity in mortality by state

Ca-A Cancer Journal for Clinicians, 2017
Carol E Desantis, Ann Goding Sauer Msph, Lisa A Newman   +2 more
exaly  

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly  

Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Elizabeth A Mittendorf, Hope S Rugo, Gabriel N Hortobagyi   +2 more
exaly  

Anti-mullerian hormone (AMH) and IVF outcomes

Fertility and Sterility, 2007
R.M. Riggs, T.D. Kimble, B.S. Leader, Z. Jie, L.A. Stadtmauer   +4 more
openaire   +1 more source

Hypercalcemia and cancer: Differential diagnosis and treatment

Ca-A Cancer Journal for Clinicians, 2018
Sarah B Fisher
exaly  

Current Knowledge of Anti-Mullerian Hormone (AMH)

JBRA Assisted Reproduction, 2011
Juliano Augusto Brum Scheffer, Rafaela Friche Brum Scheffer, Erika Lima Pimenta, Bruno Brum Scheffer   +3 more
openaire   +1 more source

Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea

Ca-A Cancer Journal for Clinicians, 2018
Clement Chung
exaly